menu
    • menu

    Company profile for TechnoDerma Medicines

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tekoro Company is an innovative small-molecule drug research and development enterprise focusing on the research and development of new skin diseases. It is located in Jiaxing Xiuzhou Biomedicine Guoqian Park. It is a leading enterprise introduced by the Jiaxing Municipal Government of Zhejiang Province. At present, the company's multiple research and development projects are progressing smoothly, and it is expected that 3...
    Tekoro Company is an innovative small-molecule drug research and development enterprise focusing on the research and development of new skin diseases. It is located in Jiaxing Xiuzhou Biomedicine Guoqian Park. It is a leading enterprise introduced by the Jiaxing Municipal Government of Zhejiang Province. At present, the company's multiple research and development projects are progressing smoothly, and it is expected that 3-4 new class I small molecule drugs will enter clinical phase I and phase II trials in 2023-2024.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TechnoDerma MedicinesChina Flag
    Country
    Country
    China
    Address
    Address
    Building B, No. 51, Wufeng Road, Xiuzhou District, Jiaxing City, Zhejiang Prov...
    Telephone
    Telephone
    0573-82795671
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.tkskin.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Technoderma Completes Ph2a Proof-Of-Concept For TDM-180935
    Technoderma Completes Ph2a Proof-Of-Concept For TDM-180935

    06 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/technoderma-medicines-completes-positive-ph2a-proof--of-concept-trial-with-topical-tdm-180935-ointment-for-atopic-dermatitis-302342710.html

    PR NEWSWIRE
    06 Jan 2025
    Share Share
    TechnodermaAdvances TDM-180935 to Phase 2 in Atopic Dermatitis
    TechnodermaAdvances TDM-180935 to Phase 2 in Atopic Dermatitis

    29 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/technoderma-medicines-advances-tdm-180935-atopic-dermatitis-clinical-program-with-phase-2-trial-302129786.html

    PR NEWSWIRE
    29 Apr 2024
    Share Share
    Technoderma Phase 2 of TDM-105795 Shows Hair Growth in Androgenetic Alopecia
    Technoderma Phase 2 of TDM-105795 Shows Hair Growth in Androgenetic Alopecia

    05 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/technoderma-medicines-phase-2-clinical-trial-of-tdm-105795-demonstrates-hair-growth-in-androgenetic-alopecia-302052631.html

    PR NEWSWIRE
    05 Feb 2024
    Share Share
    Technoderma Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935
    Technoderma Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935

    04 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/technoderma-medicines-completes-phase-1-dose-escalation-clinical-trial-of-tdm-180935-for-atopic-dermatitis-302004584.html

    PR NEWSWIRE
    04 Dec 2023
    Share Share
    Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Ph2 Trial
    Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Ph2 Trial

    18 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/technoderma-medicines-initiates-tdm-105795-androgenetic-alopecia-phase-2-clinical-trial-301800212.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search